Hanmi Selects Medidata Cloud Technology

Published on: 

Medidata has signed a multi-year deal with South Koreas Hanmi Pharmaceuticals.

Medidata has signed a multi-year deal with South Korea's Hanmi Pharmaceuticals. The Seoul-based company is adopting Medidatas Clinical Cloud platform into all clinical trials across its drug development programs.

Read the full release here